Intragraft messenger RNA expression of angiotensinogen: Relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients

Valeria Mas, T. Alvarellos, C. Giraudo, P. Massari, Graciela De Boccardo

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Transforming growth factor (TGF)-β1 is important in fibrogenesis and has been involved in the pathogenesis of chronic allograft nephropathy (CAN). The angiotensinogen (AGT) gene encodes the only glycoprotein known to be a precursor of the vasopressor angiotensin II. Angiotensin II is also a growth factor and a profibrogenic cytokine. It mediates the induction of TGF-β1. We studied the relationship among the intragraft expression of AGT, TGF-β1, and CAN in stable renal transplant patients (RTP). We used a competitive quantitative reverse transcriptase-polymerase chain reaction (RT-PCR)-ELISA assay to identify intragraft amounts of AGT expression in RTP and correlated it with TGF-β1 mRNA expression. We studied and performed kidney biopsies on 12 RTP with long-functioning grafts and 6 RTP in the immediate posttransplantation period (7 days) who had acute tubular necrosis as control. Histology was based on Banff working classification criteria. Total RNA was isolated from biopsy specimens. For RT-PCR-ELISA, we created heterologous RNA competitors that coamplified with the same primers as AGT and TGF-β1. Six of 12 long RTP had proteinuria > 1000 mg/24 hr and 6 had proteinuria < 1000 mg/24 hr. The differences between Banff grades (P=0.03), AGT, and TGF-β1 levels by RTPCR-ELISA were statistically significant between both groups (106.2±60.7 vs. 34.1±11.9 pg/μg total RNA [P=0.01] and 5954±5612 vs. 436±517 transcripts/μg total RNA [P=0.01], respectively). The control group showed AGT levels of 25±12.2 pg/μg total RNA and TGF-β1 levels of 228±111 transcripts/μg total RNA, significant only for the higher proteinuria group (P=0.01 and P=0.04, respectively). There was a correlation between AGT and TGF-β1 in both groups (r=0.96, P=0.001). We showed a relationship between mRNA expression of AGT and TGF-β1 in kidney transplant patients with different grades of CAN and proteinuria.

Original languageEnglish (US)
Pages (from-to)718-721
Number of pages4
JournalTransplantation
Volume74
Issue number5
DOIs
StatePublished - Sep 15 2002
Externally publishedYes

Fingerprint

Angiotensinogen
Transforming Growth Factors
Transforming Growth Factor beta
Allografts
Transplants
Kidney
Messenger RNA
RNA
Proteinuria
Enzyme-Linked Immunosorbent Assay
Reverse Transcriptase Polymerase Chain Reaction
Angiotensin II
Biopsy
Intercellular Signaling Peptides and Proteins
Histology
Glycoproteins
Necrosis
Cytokines
Control Groups

All Science Journal Classification (ASJC) codes

  • Transplantation

Cite this

Intragraft messenger RNA expression of angiotensinogen : Relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients. / Mas, Valeria; Alvarellos, T.; Giraudo, C.; Massari, P.; De Boccardo, Graciela.

In: Transplantation, Vol. 74, No. 5, 15.09.2002, p. 718-721.

Research output: Contribution to journalArticle

@article{f08b305116fb410b9e92464b33e8e0b6,
title = "Intragraft messenger RNA expression of angiotensinogen: Relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients",
abstract = "Transforming growth factor (TGF)-β1 is important in fibrogenesis and has been involved in the pathogenesis of chronic allograft nephropathy (CAN). The angiotensinogen (AGT) gene encodes the only glycoprotein known to be a precursor of the vasopressor angiotensin II. Angiotensin II is also a growth factor and a profibrogenic cytokine. It mediates the induction of TGF-β1. We studied the relationship among the intragraft expression of AGT, TGF-β1, and CAN in stable renal transplant patients (RTP). We used a competitive quantitative reverse transcriptase-polymerase chain reaction (RT-PCR)-ELISA assay to identify intragraft amounts of AGT expression in RTP and correlated it with TGF-β1 mRNA expression. We studied and performed kidney biopsies on 12 RTP with long-functioning grafts and 6 RTP in the immediate posttransplantation period (7 days) who had acute tubular necrosis as control. Histology was based on Banff working classification criteria. Total RNA was isolated from biopsy specimens. For RT-PCR-ELISA, we created heterologous RNA competitors that coamplified with the same primers as AGT and TGF-β1. Six of 12 long RTP had proteinuria > 1000 mg/24 hr and 6 had proteinuria < 1000 mg/24 hr. The differences between Banff grades (P=0.03), AGT, and TGF-β1 levels by RTPCR-ELISA were statistically significant between both groups (106.2±60.7 vs. 34.1±11.9 pg/μg total RNA [P=0.01] and 5954±5612 vs. 436±517 transcripts/μg total RNA [P=0.01], respectively). The control group showed AGT levels of 25±12.2 pg/μg total RNA and TGF-β1 levels of 228±111 transcripts/μg total RNA, significant only for the higher proteinuria group (P=0.01 and P=0.04, respectively). There was a correlation between AGT and TGF-β1 in both groups (r=0.96, P=0.001). We showed a relationship between mRNA expression of AGT and TGF-β1 in kidney transplant patients with different grades of CAN and proteinuria.",
author = "Valeria Mas and T. Alvarellos and C. Giraudo and P. Massari and {De Boccardo}, Graciela",
year = "2002",
month = "9",
day = "15",
doi = "10.1097/00007890-200209150-00022",
language = "English (US)",
volume = "74",
pages = "718--721",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Intragraft messenger RNA expression of angiotensinogen

T2 - Relationship with transforming growth factor beta-1 and chronic allograft nephropathy in kidney transplant patients

AU - Mas, Valeria

AU - Alvarellos, T.

AU - Giraudo, C.

AU - Massari, P.

AU - De Boccardo, Graciela

PY - 2002/9/15

Y1 - 2002/9/15

N2 - Transforming growth factor (TGF)-β1 is important in fibrogenesis and has been involved in the pathogenesis of chronic allograft nephropathy (CAN). The angiotensinogen (AGT) gene encodes the only glycoprotein known to be a precursor of the vasopressor angiotensin II. Angiotensin II is also a growth factor and a profibrogenic cytokine. It mediates the induction of TGF-β1. We studied the relationship among the intragraft expression of AGT, TGF-β1, and CAN in stable renal transplant patients (RTP). We used a competitive quantitative reverse transcriptase-polymerase chain reaction (RT-PCR)-ELISA assay to identify intragraft amounts of AGT expression in RTP and correlated it with TGF-β1 mRNA expression. We studied and performed kidney biopsies on 12 RTP with long-functioning grafts and 6 RTP in the immediate posttransplantation period (7 days) who had acute tubular necrosis as control. Histology was based on Banff working classification criteria. Total RNA was isolated from biopsy specimens. For RT-PCR-ELISA, we created heterologous RNA competitors that coamplified with the same primers as AGT and TGF-β1. Six of 12 long RTP had proteinuria > 1000 mg/24 hr and 6 had proteinuria < 1000 mg/24 hr. The differences between Banff grades (P=0.03), AGT, and TGF-β1 levels by RTPCR-ELISA were statistically significant between both groups (106.2±60.7 vs. 34.1±11.9 pg/μg total RNA [P=0.01] and 5954±5612 vs. 436±517 transcripts/μg total RNA [P=0.01], respectively). The control group showed AGT levels of 25±12.2 pg/μg total RNA and TGF-β1 levels of 228±111 transcripts/μg total RNA, significant only for the higher proteinuria group (P=0.01 and P=0.04, respectively). There was a correlation between AGT and TGF-β1 in both groups (r=0.96, P=0.001). We showed a relationship between mRNA expression of AGT and TGF-β1 in kidney transplant patients with different grades of CAN and proteinuria.

AB - Transforming growth factor (TGF)-β1 is important in fibrogenesis and has been involved in the pathogenesis of chronic allograft nephropathy (CAN). The angiotensinogen (AGT) gene encodes the only glycoprotein known to be a precursor of the vasopressor angiotensin II. Angiotensin II is also a growth factor and a profibrogenic cytokine. It mediates the induction of TGF-β1. We studied the relationship among the intragraft expression of AGT, TGF-β1, and CAN in stable renal transplant patients (RTP). We used a competitive quantitative reverse transcriptase-polymerase chain reaction (RT-PCR)-ELISA assay to identify intragraft amounts of AGT expression in RTP and correlated it with TGF-β1 mRNA expression. We studied and performed kidney biopsies on 12 RTP with long-functioning grafts and 6 RTP in the immediate posttransplantation period (7 days) who had acute tubular necrosis as control. Histology was based on Banff working classification criteria. Total RNA was isolated from biopsy specimens. For RT-PCR-ELISA, we created heterologous RNA competitors that coamplified with the same primers as AGT and TGF-β1. Six of 12 long RTP had proteinuria > 1000 mg/24 hr and 6 had proteinuria < 1000 mg/24 hr. The differences between Banff grades (P=0.03), AGT, and TGF-β1 levels by RTPCR-ELISA were statistically significant between both groups (106.2±60.7 vs. 34.1±11.9 pg/μg total RNA [P=0.01] and 5954±5612 vs. 436±517 transcripts/μg total RNA [P=0.01], respectively). The control group showed AGT levels of 25±12.2 pg/μg total RNA and TGF-β1 levels of 228±111 transcripts/μg total RNA, significant only for the higher proteinuria group (P=0.01 and P=0.04, respectively). There was a correlation between AGT and TGF-β1 in both groups (r=0.96, P=0.001). We showed a relationship between mRNA expression of AGT and TGF-β1 in kidney transplant patients with different grades of CAN and proteinuria.

UR - http://www.scopus.com/inward/record.url?scp=0037106361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037106361&partnerID=8YFLogxK

U2 - 10.1097/00007890-200209150-00022

DO - 10.1097/00007890-200209150-00022

M3 - Article

C2 - 12352892

AN - SCOPUS:0037106361

VL - 74

SP - 718

EP - 721

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 5

ER -